We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

57 hedge funds and large institutions have $109M invested in Annovis Bio in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more capital invested

Capital invested by funds: $23.1M → $109M (+$85.8M)

371% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 7

84% more funds holding

Funds holding: 31 → 57 (+26)

4.01% more ownership

Funds ownership: 12.01% → 16.01% (+4%)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

Holders
57
Holders Change
+26
Holders Change %
+83.87%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
10
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Voloridge Investment Management
Voloridge Investment Management
Florida
+$4.73M
2
BlackRock
BlackRock
New York
+$4.67M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.81M
4
KCM
Knoll Capital Management
Florida
+$1.81M
5
Morgan Stanley
Morgan Stanley
New York
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$4.15M
2
Renaissance Technologies
Renaissance Technologies
New York
-$555K
3
SIAP
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
-$513K
4
LIG
Lokken Investment Group
Delaware
-$486K
5
BFM
Boothbay Fund Management
New York
-$472K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$19.6M +$3.81M +82,452 +56%
ACM
2
AIGH Capital Management
Maryland
$10.8M +$426K +9,213 +8%
IC
3
Ikarian Capital
Texas
$8.86M -$4.15M -89,841 -46%
Voloridge Investment Management
4
Voloridge Investment Management
Florida
$8.76M +$4.73M +102,401 New
BlackRock
5
BlackRock
New York
$8.64M +$4.67M +100,997 New
EI
6
EAM Investors
California
$4.16M +$185K +4,003 +9%
KCM
7
Knoll Capital Management
Florida
$3.36M +$1.81M +39,210 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.3M +$508K +10,986 +40%
MWM
9
Modera Wealth Management
New Jersey
$2.97M -$273K -5,900 -15%
WVP
10
Worth Venture Partners
New Jersey
$2.9M +$179K +3,866 +13%
Morgan Stanley
11
Morgan Stanley
New York
$2.57M +$1.39M +30,070 New
EGI
12
EAM Global Investors
California
$2.53M +$1.37M +29,590 New
Goldman Sachs
13
Goldman Sachs
New York
$2.21M +$1.19M +25,819 New
BCM
14
Bridgeway Capital Management
Texas
$2.02M +$50.8K +1,100 +5%
PPA
15
Parametric Portfolio Associates
Washington
$1.91M +$1.03M +22,331 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$1.9M +$1.02M +22,168 New
SIAP
17
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$1.76M -$513K -11,104 -35%
LSA
18
L & S Advisors
California
$1.67M +$902K +19,530 New
VF
19
Virtu Financial
New York
$1.49M +$439K +9,491 +119%
State Street
20
State Street
Massachusetts
$1.48M +$799K +17,300 New
CC
21
Cannell & Co
New York
$1.37M +$277K +6,000 +60%
SEI Investments
22
SEI Investments
Pennsylvania
$1.3M +$704K +15,244 New
DC
23
Diametric Capital
Massachusetts
$1.07M -$202K -4,379 -26%
ACM
24
ACT Capital Management
Pennsylvania
$1.03M +$554K +12,000 New
BFM
25
Boothbay Fund Management
New York
$1.01M -$472K -10,211 -46%
1
2 3

ANVS Hedge Fund Activity: Q2 2021 in Review

57 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q2 2021, worth a combined $109M — up 371% from $23.1M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ANVS positions and 7 closed out — a net gain of 26 holders — while 10 added to existing stakes and 12 trimmed.

The largest buyer was Voloridge Investment Management, opening a new position worth an estimated $4.73M. The largest seller was Ikarian Capital, cutting an estimated $4.15M.

  • 57 institutional investors held Annovis Bio (ANVS) as of Q2 2021, up from 31 in Q1 2021.
  • Funds reported $109M of Annovis Bio stock for Q2 2021, up 371% quarter-over-quarter.
  • 33 funds opened new Annovis Bio positions in Q2 2021 and 7 closed out, a net change of +26 holders.
  • The largest Annovis Bio buyer in Q2 2021 was Voloridge Investment Management, an estimated $4.73M added.
  • The largest Annovis Bio seller in Q2 2021 was Ikarian Capital, an estimated $4.15M sold.

Based on aggregated 13F filings for Q2 2021.